Full-Time

Clinical Program Manager

Oncology

Posted on 10/30/2024

Eikon Therapeutics

Eikon Therapeutics

201-500 employees

Biotech startup developing innovative medicines

AI & Machine Learning
Biotechnology

Compensation Overview

$156.2k - $171.8kAnnually

+ Bonus + Equity Compensation

Mid, Senior

New York, NY, USA + 1 more

More locations: Hayward, CA, USA

Requires onsite presence a minimum of 3 days a week.

Category
Project Management
Business & Strategy
Requirements
  • PhD with 3 years of relevant experience, or a Master’s Degree with 6 years of relevant experience, or a Bachelor’s Degree with 8 years of relevant experience in life sciences, healthcare, or related field preferred.
  • Proficiency in one or more European languages and fluency in English (strong reading, writing, and speaking skills and an ability to effectively communicate with colleagues and stakeholders at all levels) is required.
  • In-depth knowledge of ICH-GCP, EMEA guidelines and other relevant regulations and guidelines.
  • Proficient in using clinical trial management systems (CTMS, RTSM, Veeva Vault suite) and electronic data capture (EDC) systems.
  • Proven ability to manage clinical studies within timelines and budgets while maintaining high quality standards and patient safety.
  • Strong leadership and communication skills, with a demonstrated ability to work collaboratively with cross-functional teams.
  • Experience with management of the budget, resources, headcount, processes and controls, productivity, quality and project delivery.
  • High sense of accountability and urgency in order to prioritize deliverables.
  • Growth mindset and capable of working independently.
  • Ability to work onsite at least 3 days a week.
  • Ideally has PMP certification.
Responsibilities
  • Team leader and builder, who manages trial deliverables, timelines in assigned protocols to meet country commitments and regulatory requirements.
  • Works with minimal oversight from Clinical Operations Senior Director or Director, in collaboration with Clinical Operations teams and Clinical Research and Development functional teams.
  • Ensure that clinical studies are conducted in accordance with approved protocols, ICH-GCP, EMEA, PMDA and other relevant regulations and guidelines.
  • Manage ancillary (non CRO) vendor relationships and performance to ensure that clinical studies are completed in accordance with contract specifications of time, cost and quality ensuring compliance with applicable regulations, guidelines, and company policies.
  • Work with finance, legal, external vendors and clinical sites to ensure the assigned studies are meeting the target milestones.
  • Provide direction to cross-functional study teams to ensure successful study execution.
  • Provide regular updates on study progress to stakeholders (e.g., Clinical Operations, Project & Portfolio Management, Clinical Research).
  • Ensure that all study-related documents are accurate, complete, timely and filed appropriately in all clinical (Veeva TMF), regulatory, safety and finance systems.
  • Oversee and be in compliance with Eikon processes, SOPs, clinical supply and ancillary supplies management, import/export requirements, insurance supply management.
  • Expected to lead, manage, hire global regional Clinical Operations Study Management personnel, as required, to support operational excellence.
  • Contribute to initiatives and projects adding value to Eikon Therapeutics.

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic behavior of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that enhance and prolong life. A key aspect of their work is a proprietary single-molecule tracking (SMT) platform that visualizes protein movements in living cells, enabling them to analyze molecular interactions with high precision. Eikon Therapeutics aims to serve patients with serious diseases by developing effective treatments and generates revenue through the commercialization of these therapies.

Company Stage

Series C

Total Funding

$750.8M

Headquarters

Hayward, California

Founded

2019

Growth & Insights
Headcount

6 month growth

6%

1 year growth

10%

2 year growth

51%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eikon's SMT technology aligns with the precision medicine trend, enhancing personalized treatments.
  • The partnership with Impact Therapeutics boosts Eikon's targeted cancer therapy capabilities.
  • Eikon's new Jersey City office attracts top talent and fosters innovation.

What critics are saying

  • Competition from biotech unicorns like Abogen Biosciences may impact Eikon's market position.
  • Expansion of the drug pipeline could strain Eikon's resources and operational capacity.
  • Dependency on external partners like Impact Therapeutics poses potential collaboration risks.

What makes Eikon Therapeutics unique

  • Eikon's SMT platform offers real-time, molecular-resolution measurements of protein movement in cells.
  • The company integrates biology, engineering, and chemistry for novel drug discovery approaches.
  • Eikon's diverse team combines expertise in data science, biology, and engineering.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE